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Abstract
The T lymphocyte plasma membrane condenses at the site of activation but the functional significance of this receptor-
mediated membrane reorganization is not yet known. Here we demonstrate that membrane condensation at the T cell
activation sites can be inhibited by incorporation of the oxysterol 7-ketocholesterol (7KC), which is known to prevent the
formation of raft-like liquid-ordered domains in model membranes. We enriched T cells with 7KC, or cholesterol as control,
to assess the importance of membrane condensation for T cell activation. Upon 7KC treatment, T cell antigen receptor (TCR)
triggered calcium fluxes and early tyrosine phosphorylation events appear unaltered. However, signaling complexes form
less efficiently on the cell surface, fewer phosphorylated signaling proteins are retained in the plasma membrane and actin
restructuring at activation sites is impaired in 7KC-enriched cells resulting in compromised downstream activation
responses. Our data emphasizes lipids as an important medium for the organization at T cell activation sites and strongly
indicates that membrane condensation is an important element of the T cell activation process.
Citation: Rentero C, Zech T, Quinn CM, Engelhardt K, Williamson D, et al. (2008) Functional Implications of Plasma Membrane Condensation for T Cell
Activation. PLoS ONE 3(5): e2262. doi:10.1371/journal.pone.0002262
Editor: Francois Schweisguth, Ecole Normale Superieure, France
Received November 7, 2007; Accepted April 19, 2008; Published May 28, 2008
Copyright:  2008 Rentero et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: TZ is recipient of an EPA studentship, TH is an EPA senior fellow. The work in T.H. laboratory was supported by the Wellcome trust project grant
082782/2/07/2. KG acknowledges funding from the Australian Research Council and the National Health & Medical Research Council of Australia.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: thomas.harder@path.ox.ac.uk (TH); k.gaus@unsw.edu.au (KG)
. These authors contributed equally to this work.
Introduction
Signals for T lymphocyte activation are transmitted at the
contact zone between the T cell and a cognate antigen presenting
cell (APC) [1]. The key T cell activating stimulus at the so-called
immunological synapse (IS) is initiated by the T cell antigen
receptor (TCR) upon binding to its cognate peptide-MHC
(pMHC) ligand presented on the surface of an APC [2]. The T
cell activation process is tightly coupled to spatial segregation of
proteins and lipids into T cell plasma membrane domains at the
IS. Segregation of these domains in the T cell plasma membrane
follows several distinctive mechanisms.
Following TCR triggering, signaling protein complexes assem-
ble in plasma membrane domains in vicinity of the TCR [3,4].
Membrane-attached Src kinase Lck phosphorylates subunits of the
TCR/CD3 complex leading to further recruitment and phos-
phorylation of cytosolic ZAP70 tyrosine kinase. ZAP70 phosphor-
ylates tyrosine residues of the transmembrane protein Linker for
Activation of T cells (LAT). Subsequently, LAT establishes a
cooperative network of cytoplasmic signaling proteins such as the
adaptor protein Grb2 and signaling enzyme PLCc in the vicinity
of activated TCR [5]. These multi-protein TCR LAT assemblies
(TLAs) mediate the immediate downstream signals following TCR
engagement [4] such as Ras activation [6] and induction of Ca
2+
fluxes [7].
In addition to signaling complexes, organization of IS membrane
domains is also driven by interaction of membrane bound proteins
with the actin cytoskeleton. Consequently, T cells deficient in
proteins which regulate and mediate actin cytoskeletal rearrange-
ments have defects in IS formation and T cell activation [5,8,9].
Important steps of the T cell activation cascade have been
proposed to occur in raft domains of the T cell plasma membrane.
Based on studies of model membranes, lipid rafts are defined as
liquid-ordered (lo) membrane phases coexisting with a liquid-
disordered (ld) phase of the non-raft environment in the lipid
bilayers [10]. The phase separation into lo/ld critically depends on
the presence of cholesterol. In the lo phase, the planar sterol group
of cholesterol is believed to align with saturated hydrocarbon
chains of sphingolipids and phosphoglycerides resulting in tight
lipid packing and condensation of the lipid bilayers [10,11].
Lo phases in model membranes resist solubilisation by several
non-ionic detergents such as Triton6100 [12]. Thus, biochemical
analysis of detergent resistant membranes (DRMs) isolated from
cells was used to deduce the molecular composition of rafts. Based
on these analyses, cell membrane rafts were proposed to be
enriched in cholesterol, sphingolipids, and specific membrane
proteins such as glycosylphosphatidyl-inositol (GPI)-anchored
proteins in the outer leaflet and dual-acylated proteins anchored
in the inner leaflet. However due to numerous ambiguities of
detergent treatment, significant concerns were raised as to the
extent to which DRMs represent domains of intact cell
membranes [13,14].
The involvement of membrane rafts as signaling platforms at
the T cell activation sites was initially proposed based on the
PLoS ONE | www.plosone.org 1 May 2008 | Volume 3 | Issue 5 | e2262association of several membrane-associated TCR signaling
proteins with DRMs [15], including acylated Src-related tyrosine
kinases Lck and Fyn, acylated transmembrane linkers and TCR
components. However, microscopy studies of intact T cells
revealed no coclustering of generic DRM-associated raft markers
such as GPI-anchored raft reporter proteins with activated TCR
[16]. In contrast, the membrane polarity reporter Laurdan
revealed unequivocally the formation of condensed plasma
membrane domains at T cell activation sites [17] demonstrating
physical hallmarks of rafts at these membrane regions.
The functional role of raft domains in T cell activation has been
previously examined by disrupting ordered membrane phases by
depletion of endogenous cholesterol using methyl-b-cyclodextrin
(mbCD) [18–20] or cholesterol oxidase [19,20]. In line with the
cholesterol dependence of lo phase formation, mbCD extraction
reduces the accumulation of condensed raft domains at T cell
activation sites [17] and causes the loss of DRM association of Lck
and LAT [18]. MbCD-mediated cholesterol extraction also
resulted in the inhibition of a key early T cell activation
response-the induction Ca
2+ fluxes in response to TCR triggering.
Further analyses showed that mbCD extraction led to depletion of
Ca
2+ from intracellular stores which are essential for T cell
activation [20]. Thus manipulation of cholesterol can disrupt
several T cell functions, which makes it difficult to draw
conclusions and the functional role of plasma membrane
condensation in T cell activation responses remains a fundamen-
tally important, yet unanswered question. Here, we specifically
inhibit membrane condensation at T-cell activation sites using the
oxysterol 7-ketocholesterol (7KC), which inhibits tight packing of
saturated acyl chains and monitor the effects of 7KC on T cell
signaling and early activation responses.
Results
Inhibition of membrane condensation at T cell activation
sites by 7-ketocholesterol
The T cell plasma membrane bilayer condenses at the site of
activation within minutes post stimulation [17]. In order to
specifically interfere with this condensation we incorporated 7-
ketocholesterol (7KC) into naı ¨ve T cells and T cell lines. 7KC
differs from cholesterol only by an additional ketone group, which
protrudes perpendicular from the cholesterol ring. While cellular
processing and intracellular trafficking of 7KC is identical to
cholesterol [21], substitution of 7KC for cholesterol decreases lipid
order and increases bilayer polarity [22].
We incubated Jurkat-derived T cell lines or primary T cells with
identical amounts of sterols (58 mM)-either cholesterol (CH) or
7KC alone, or as mixtures of CH and 7KC at 2:1 or 1:2 molar
ratios. Sterols were incubated with the cells as water-soluble
complexes with methyl-b-cyclodextrin (mbCD). The mbCD
concentration in these experiments was 0.5 mM which is ,2–
20-fold lower than the concentration generally used for extraction
of endogenous cholesterol from cells. Control cells were neither
incubated with sterols nor with mßCD. In both Jurkat-derived T
cell lines, sterol treatment resulted in a 1.4–2.0-fold increase of
total cellular sterol levels (Table 1A). Upon sterol enrichment,
similar cholesterol levels were measured in all treatment conditions
in Jurkat 8.2 cells (38.368.1 nmol/mg protein) and in JCaM2 wt
LAT cells (35.067.6 nmol/mg protein). 7KC levels ranged from
0–68% of total sterol (0–40 nmol/mg protein in Jurkat 8.2 cells; 0–
38 nmol/mg protein in JCaM2 wt LAT cells).
Sterol-treated Jurkat 8.2 cells, which express the 5C.C7 TCR
reactive to the moth cytochrome C (MCC) peptide 87–103 in
the context of IEk class II MHC, were conjugated with6MCC
peptide-pulsed CH27 IEk expressing B-cells (Fig. 1). JCaM2 wt
LAT cells, which are fully TCR responsive, were conjugated to
polystyrene beads coated with TCR-activating anti-CD3
monoclonal antibodies (mAb) or with anti-transferrin receptor
(TfR) mAb coated control beads which do not activate T cells
(Fig. 2).
Plasma membrane structure at the respective T cell activation
sites was visualized (Fig. 1A, B; Fig. 2A, B) and quantified
(Fig. 1C, D; Fig. 2C, D) as described previously [17] using the
fluorescent membrane dye Laurdan (5 mM labeling concentra-
tion) and 2-photon microscopy. Laurdan shifts its peak emission
wavelength from ,500 nm in fluid to ,440 nm in ordered
membranes [23]. Thus the normalized ratio of two, simulta-
neously recorded, intensity channels, defined as the generalized
polarization (GP), is a relative measure of membrane order with
fluid domains in cellular membranes yielding typically a GP value
below 0.3 [24].
To demonstrate that interactions with TCR membrane proteins
are not solely responsible for the spectral properties of the probe,
we conducted fluorescence resonance energy transfer (FRET)
studies in activated T cells using tryptophan fluorescence as a
donor for Laurdan excitation [25]. At low Laurdan concentrations
in the labeling media (,10 mM), Laurdan was not in the vicinity of
tryptophan-containing proteins to result in detectable FRET. High
levels of the probe resulted in FRET (Fig. S1A) concomitant with a
small increase in mean GP value at the activation site (Fig. S1B).
The high concentrations of Laurdan required to achieve FRET
indicate that the probe does not specifically interact with proteins.
Further Laurdan within the vicinity of proteins reports similar GP
values than outside the FRET range (estimated to be 14 A ˚ in
liposomes [25]) with a variation in mean GP of60.04. Thus the
probe is likely to report the overall membrane structure of a
defined region.
GP values were pseudo-colored in cell images, as indicated in
Figs. 1A and 2A. We measured the contact site between MCC
peptide-pulsed versus not pulsed CH27 B-cells with Jurkat 8.2 cells
(Fig. 1) and between JCaM2 wt LAT cells and beads coated with
monoclonal antibodies (mAb) to CD3 versus transferrin receptor
(TfR, Fig. 2) to compare GP values at activation with those of non-
activation control sites. As previously reported [17], we observed a
significant condensation at the site of Jurkat 8.2 cell activation by B
cells pulsed with antigenic peptide (Fig. 1A, Table 1B) and the site
of JCaM2 wt LAT cell contacts with anti-CD3 coated beads
(Fig. 2A, Table 1B). Cholesterol-only treatment did not affect this
activation-induced increase in membrane condensation, but 7KC
significantly reduced mean GP values and hence membrane
condensation at the T cell activation sites in a dose dependent
manner (Fig. 1 and Fig. 2; Table 1).
Under most 7KC loading conditions, we observed little effect on
the order of the plasma membrane outside T cell activation sites.
However, at the highest 7KC dose used, we observed a reduction
of the mean GP value (from ,0.22 to 0.123) at the sites of
conjugation of JCaM2 wt LAT cells with anti-TfR coated beads
(Fig. 2D). To further evaluate the global effects of 7KC on
membrane density, we deconvoluted the GP distribution of the cell
images to discriminate fluid and ordered membrane populations
(mean GP and coverage in parentheses, Table 1C), as described
earlier [17,24]. With increasing doses of 7KC in CD3-activated
JCaM2 wt LAT cells, the proportion of the ordered membrane
population decreased from 23% to 11% while the mean GP value
of this population did not change significantly. Non-stimulated
cells exhibited no significant decrease in the ordered membrane
population in response to 7KC (from 10.3% to 9.4%). Thus we
established conditions at which 7KC appears to specifically impair
Membrane Condensation
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membranes and control, non-activation sites are not affected.
Effects of sterol enrichment on cell viability and protein
expression
It has been previously reported that high levels of 7KC induces
apoptosis by activating caspases [26,27] and generating reactive
oxygen species (ROS) [28]. We performed a series of experiments
to exclude the possibility that 7KC treatment had other effects,
which may be responsible for reduced T cell activation responses.
First, we tested whether 7KC caused cell death (Fig. 3A) as high
levels of 7KC have been previously reported to be cytotoxic in
some cells [29]. Indeed, we did observe increased cell death at the
highest 7KC loading (P,0.05) compared to control or cholesterol-
enriched cells but enrichment with lower 7KC concentrations with
2:1 CH:7KC or 2:1 CH:7KC had no significant effect (P.0.05) on
cell viability. Similarly, only cells enriched with the highest 7KC
concentration displayed a change in mitochondrial potential (Fig.
S2A), while lower concentrations had no significant effect. ATP
levels were decreased in all sterol loading conditions with no
differences between cholesterol and 7KC enrichment (Fig. S2B).
Table 1. Effect of sterol treatment on membrane composition and structure.
A. Sterol composition
JCaM2 cells Jurkat 8.2
Treatments CH+7KC nmol/mg 7KC (%) CH+7KC nmol/mg 7KC (%)
Control 30.7864.92 Not detect. 35.6561.61 Not detect.
CH 42.9064.75 Not detect. 48.9063.87 Not detect.
2:1 CH:7KC 52.9469.86 20.761.38 54.9564.07 20.6061.24
1:2 CH:7KC 58.8969.75 41.064.43 57.8561.46 39.6963.23
7KC 62.2665.11 68.465.53 53.7260.41 58.7263.36
B. GP values at TCR activation and control sites
JCaM2 wt LAT, 7 min Anti CD3 Ab beads Anti TfR Ab beads
Control 0.43760.054 (86)
** 0.22060.076 (78)
CH 0.43760.063 (76)
** 0.22760.098 (62)
2:1 CH:7KC 0.32560.080 (78)
** 0.21560.087 (60)
1:2 CH:7KC 0.24760.078 (75) 0.22860.091 (61)
7KC 0.13060.078 (80) 0.12360.069 (60)
Jurkat 8.2, 7min With Antigen Without Antigen
Control 0.42560.061 (37)
** 0.20160.066 (36)
CH 0.45460.045 (37)
** 0.21060.072 (34)
2:1 CH:7KC 0.30660.066 (39)
** 0.20760.075 (33)
1:2 CH:7KC 0.26260.079 (39)
* 0.21660.064 (33)
7KC 0.22160.086 (38) 0.21660.072 (36)
Jurkat 8.2, 23min With Antigen Without Antigen
Control 0.34260.073 (44)
** 0.22360.073 (38)
CH 0.33760.079 (39)
** 0.20060.073 (33)
2:1 CH:7KC 0.27660.073 (39)
** 0.20660.075 (39)
1:2 CH:7KC 0.23560.078 (41) 0.20360.080 (31)
7KC 0.18160.082 (45) 0.18660.059 (35)
C. Mean GP (and percentage coverage) of fluid and ordered populations
JCaM2 wt LAT, 7min Anti CD3 Ab beads Anti TfR Ab beads
Fluid/Ordered populations Fluid/Ordered population
Control 0.239 (77.7%) 0.400 (22.3%) 0.245 (89.6%) 0.409 (10.3%)
CH 0.246 (76.5%) 0.422 (23.5%) 0.251 (88.6%) 0.429 (11.4%)
2:1 CH:7KC 0.239 (83.2%) 0.402 (16.8%) 0.250 (88.6%) 0.394 (11.4%)
1:2 CH:7KC 0.241 (86.4%) 0.393 (13.6%) 0.239 (88.7%) 0.385 (11.3%)
7KC 0.238 (86.4%) 0.382 (11.5%) 0.178 (90.6%) 0.375 (9.4%)
A. Mean6standard deviation (3 experiments) of total sterol contents (CH+7KC) of JCaM2 and Jurkat 8.2 cells are given in nmol/mg cell protein. 7KC levels are a
percentage of total sterol levels. B. Mean6standard deviation (of n images) of GP values at contact sites between JCaM2 cells and beads after 7 min of activation and
between Jurkat 8.2 cells and B cells in the presence or absence of antigen after 7 min and 23 min of activation. Statistically significant differences between activation
and control sites are indicated with
** P,0.001,
* P,0.05. C. Global GP values of JCaM2 cells after 7 min of activation. Normalized GP distributions were fitting to two
Gaussian populations (fluid and ordered). The mean GP value (and coverage) of each population is given.
doi:10.1371/journal.pone.0002262.t001
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treatment conditions in caspase-3 activation (Fig. S2C), ROS
levels (Fig. S2D) and cell size (data not shown). In summary, toxic
effects of 7KC are unlikely to explain the impaired TCR signaling
and activation responses in T cells enriched with 20% 7KC
(treated with 1:2 CH:7KC) or ,40% 7KC (1:2 CH:7KC).
We also examined the expression of key signaling proteins (Fig.
S2E) and sterol-sensitive genes (Fig. S2F) in control, cholesterol-
and 7KC-enriched cells, with no significant differences in
expression between all five conditions. However, surface expres-
sion of TCR is reduced by 20–35% in all sterol-loaded Jurkat cells
but we found no difference between cholesterol-only and 7KC-
treated cells (Fig. 3B). In the following assays, we thus analyze T
cell responses of 7KC-enriched cells relative to cholesterol-
enriched cells to compare cells with similar TCR surface
expression. In summary, the correlation between membrane
structure and signal transduction is unlikely to be a consequence
of increased T cell death or altered TCR signaling protein
expression.
Early T cell signaling activities in sterol-enriched T cells
Cholesterol depletion with mßCD has been shown to inhibit
intracellular Ca
2+ fluxes independent of membrane order (Pizzo et
al, 2002). We next tested the Ca
2+ fluxes elicited by soluble OKT3
mAb-mediated TCR triggering in 7KC-enriched Jurkat cells.
FACS analyses of Jurkat cells labeled with Indo-1 fluorescent Ca
2+
sensor (Fig. 4A) revealed no differences in mean Ca
2+ fluxes
between control, cholesterol or 7KC-enriched T cells (Fig. 4B). To
measure Ca
2+ fluxes when T cells are activated locally, sterol-
enriched cells were allowed to settle on anti-CD3 antibody-coated
coverslips on an inverted microscope. As soon as the cells made
contact with the activating surface, the fluorescence intensity of the
calcium indicator Fluo-4 was recorded. When cells were thus
activated with adhered antibodies, we also found no difference in
Figure 1. Membrane structure at immunological synapses in sterol-enriched T cells. Jurkat 8.2 T cells were treated without sterols
(control), cholesterol (CH), 2:1 CH:7KC, 1:2 CH:7KC or 7KC alone as described in Methods. Sterol-enriched, Laurdan-labeled Jurkat 8.2 cells were
conjugated to CMRA-labeled B cells for 7 min in the presence (with antigen, A, C) or absence (without antigen, B, D) of 2 mM antigen cytochrome c.
A–B. Cell couples were fixed, imaged and intensity image converted into GP images and pseudo-coloured (scale in A) as described previously. Inserts
show the corresponding transmission image with the orange fluorescence of CMRA overlaid to identify APCs. Bar 5 mm. C–D. GP values were
measured over the entire contact area between T cell-APC couples as indicated in A. Means (indicated by horizontal lines) and SDs are shown in
Table 1. In C, differences (P,0.05) were found between the means of all conditions except between control versus cholesterol and 1:2 CH:7KC versus
7KC. No differences were found in D. Difference of P,0.05 compared to control cells are marked with one asterisk; differences of P,0.05 to
cholesterol-enriched cells with two asterisks.
doi:10.1371/journal.pone.0002262.g001
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tration (Fig. 4C) or response time (data not shown). Hence, we
established conditions that inhibit membrane condensation but do
not affect TCR-mediated Ca
2+ fluxes. Thus tyrosine kinases,
adaptor proteins and signaling enzyme PLCc function sufficiently
to induce Ca
2+ fluxes upon TCR triggering.
We further tested early signaling events upon TCR triggering in
whole cell lysates by probing for tyrosine phosphorylation with
immunoblotting (Fig. 5A and B) or multiplex analysis using a
microbead suspension assay (Fig. 5C). Surprisingly, we found no
differences in the degree or rate of specific (Fig. 5B) or total
tyrosine phosphorylation of CD3f, Lck, ZAP70, LAT, ERK and
CREB (Fig. 5C). We also found no differences between the five cell
conditions in PLCc1 phosphorylation upon TCR stimulation.
Differences within an assay such as the lower phosphorylation of
Lck in cholesterol-enriched T cells were not reproduced in
independent experiments. It is possible that the assays employed
here, particularly immunoblotting, are not sensitive enough to
detect small changes in overall phosphorylation rate but it appears
that signaling activities in whole cell lysates via tyrosine
phosphorylation are unaltered in sterol-enriched T cells.
Inhibition of T cells membrane condensation impairs
assembly of TCR signaling clusters on the cell surface
Multi-molecular signaling assemblies form upon TCR trigger-
ing in T lymphocyte plasma membranes. For detergent-free
biochemical characterization of these assemblies, we immunoiso-
lated TCR signaling domains from sterol-loaded Jurkat cells and
analyzed them by immunoblotting as established previously [30].
Briefly, Jurkat T cells were conjugated on ice to magnetic beads
coated with TCR triggering anti-CD3 mAb, then activated by
incubation at 37uC. Subsequently the conjugates were homoge-
nized mechanically by nitrogen cavitation. Plasma membrane
fragments containing the TCR signaling domains bound to the
magnetic beads were retrieved with a magnet and subjected to
immunoblotting.
Figure 2. Membrane structure at activation sites in sterol-enriched T cells. Sterol-enriched JCaM2 T cells were conjugated to polystyrene
beads coated with anti-CD3 mAb (Anti CD3 mAb, A, C) or anti-transferrin receptor (Anti TfR mAb, B, D) for 7 min. A–B. Cell-bead conjugates were
fixed, imaged and intensity image converted into GP images and pseudo-coloured (scale in A) as described previously. Inserts show the
corresponding transmission image to identify the location of the bead. Bar 5 mm. C–D. GP values were measured over the entire contact area
between cells and beads. Means (indicated by horizontal lines) and SDs are shown in Table 1. In C, differences (P,0.001) were found between the
means of all conditions except between control versus cholesterol. No differences were found in D except between 7KC-treated cells and all other
conditions (P,0.05). Difference of P,0.05 compared to control cells are marked with one asterisk; differences of P,0.05 to cholesterol-enriched cells
with two asterisks.
doi:10.1371/journal.pone.0002262.g002
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LAT and PLCc (Fig. 6A). As described previously [30], activation
of non-sterol treated (control) cells resulted in formation of TCR-
LAT signaling assemblies with a strong and sustained recruitment.
In 7KC-enriched cells (2:1 CH:7KC), recruitment of CD3f,
ZAP70, LAT and PLCc is clearly less efficient with a delayed
assembly of the signaling complexes, while this is not the case in
cholesterol-enriched cells (Fig. S3A). We quantified the recruit-
ment of CD3f (Fig. 6B), ZAP70 (Fig. 6C) and LAT (Fig. 6D)
isolated from control, cholesterol and 7KC-enriched (2:1
CH:7KC) cells. The similar levels of antibody heavy chain
recovered in the immuno-isolated membrane fragments indicates
equal recovery of beads post cell homogenation (Fig. S3B). In
sterol-loaded cells, recruitment of CD3f to the anti-CD3 isolates
was only reduced in comparison to control cells, which may be
caused by the reduced TCR surface expression (Fig. 3B). In
cholesterol-loaded cells, neither the recruitment of CD3f nor of
ZAP70 and LAT to the anti-CD3 immunoisolates exhibits
significant difference to control cells. Only 7KC enrichment
resulted in a consistent and significant reduction of ZAP70 and
LAT to the anti-CD3 isolates compared to cholesterol-loaded cells.
This effect was particularly striking in the amount of LAT that was
found in the anti-CD3 isolates. In summary, we observed that
7KC reduced the formation of TCR signaling assemblies.
We independently monitored the formation of TCR activation
clusters using total internal reflection fluorescence (TIRF)
microscopy in sterol-treated Jurkat T cells (Fig. 7). The cells were
allowed to settle on anti-CD3 mAb coated coverslips for 10 min at
37uC, fixed and probed for total tyrosine phosphorylation (pY,
Fig. 7A and colored green in Fig. 7C), stained with phalloidin for
F-actin (Fig. 7B and colored red in Fig. 7C), probed for ZAP70
phosphorylated at tyrosine 319 (Fig. 7D), LAT phosphorylated at
tyrosine 191 (Fig. 7E) or PLCc1 phosphorylated at tyrosine 783
(Fig. 7F). In control and cholesterol-loaded cells, a large number of
tyrosine phosphorylation spots were visible at the activation site
surrounded by a ring of F-actin as described previously [31,32].
With increasing levels of 7KC, activation sites were smaller,
tyrosine phosphorylation positive spots reduced in number and
brightness (quantification in Fig. S4A) and the F-actin ring became
less pronounced (Fig. S4B) with some small and bright F-actin
spots visible in 7KC-enriched cells. Jurkat cells plated on poly-L-
lysine- or transferrin receptor (TfR)-coated coverslips, under all
sterol treatments spread and formed similarly bright phalloidin-
stained lamellipodia (data not shown) indicating that 7KC-
enriched cells are capable of actin polymerisation but are
specifically deficient in producing TCR signals to mediate
formation of actin rings. The intensity of phospho-ZAP70 staining
was similar in control cells and cells enriched with cholesterol or
2:1 CH:7KC but reduced significantly at higher doses of 7KC
(Fig. S4C). In contrast, phospho-LAT was significantly reduced in
all sterol conditions (Fig. S4D) correlating with the reduced TCR
surface expression (Fig. 3B). Importantly, as in immuno-isolated
TCR activation sites, 7KC enrichment reduced phospho-LAT at
the cell surface in a dose-dependent manner and to a greater
extent than cholesterol enrichment. Similarly, PLCc1 was
significantly lower in 7KC-enriched cells compared to cholester-
ol-enriched or control cells so that the degree of pLAT correlate
well with pPLCc1. In summary, the microscopy data of reduced
tyrosine phosphorylated proteins at the cell surface agrees
extremely well with our biochemical observations of diminished
signaling complexes in the plasma membrane of 7KC-enriched
cells. Taken together, our data suggests that 7KC modulates the
location of TCR signaling proteins with less signaling proteins
recruited or retain at the cell surface and this impacts more
severely on LAT or actin restructuring than on upstream
components such as ZAP70 or elements of the CD3 complex.
Downstream activation responses of sterol-enriched T
cells
We next evaluated IL-2 secretion from CD3/CD28 expanded
primary mouse lymphocytes by TCR stimulation with anti-CD3
antibody coated on 96-well plates (Fig. 8A). We also measured
activation-induced IL-2 secretion of Jurkat 8.2 T lymphoma cells
stimulated with MCC peptide-pulsed CH27 B cells (Fig. 8B). In
both cell types, 7KC incorporation into the T cell membrane
caused a dose dependent reduction of IL-2 secretion in response to
T cell activation (P,0.05 at 2:1 CH:7KC and P,0.001 at 1:2
CH:7KC and 7KC alone). The Jurkat cells treated only with
cholesterol secreted similar quantities of IL-2 as untreated controls.
In primary T cells, IL-2 secretion was lower but not significantly
reduced by the cholesterol-only treatment, which may be
explained by the lower TCR surface expression under this
condition. Similarly, to IL-2 secretion, phosphorylation of
Figure 3. Viability and TCR surface expression sterol-enriched
T cells. A. Viability of sterol-treated Jurkat cells was determined with
annexin-5 staining to detect apoptosis and propidium iodide for
necrotic cells. Viability was normalized to control cells. One asterisk
denotes P,0.001 compared to control; two asterisks indicate P,0.05
compared to cholesterol-enriched cells. B. Surface expression of CD3
was determined by flow cytometry in wild-type Jurkat and Jurkat 8.2
cells and normalized to control cells.
doi:10.1371/journal.pone.0002262.g003
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enrichment in a dose-dependent manner (Fig. S5A). We further
tested the responsiveness of sterol-enriched cells by assessing IL-2
transcription (Fig. S5B) when TCR activation is bypassed by
stimulation with ionomycin and PMA. Only when cells are treated
with 7KC alone did we find a reduced responsiveness in IL-2
transcription to non-specific activation.
Taken together, our data shows that 7KC incorporation
specifically inhibits membrane condensation at T cell activation
sites. This leads to reduced formation of LAT-based signaling
complexes at plasma membrane and a failure of actin rings to
polymerize at TCR activation sites. Consistently IL-2 secretion
upon TCR engagement is reduced. These data indicate that T cell
receptor signals are not effectively transduced when formation of
ordered membrane domains is impaired.
Discussion
The plasma membrane of T lymphocytes condenses at sites of T
cell activation to form a zone rich in ordered membrane domains
[17]. Rafts in lipid bilayers are defined as liquid-ordered (lo) phases
in a liquid-disordered (ld) non-raft environment [33]. Thus
membrane condensation at T cell activation sites is a physical
reflection of raft accumulation. Here, we address the functional
Figure 4. Calcium flux upon TCR triggering. A. Jurkat cells (untreated controls or treated with 2:1 CH:7KC) were loaded with Indo-1 and
evaluated for Ca
2+ mobilization by stimulation with 5 mg OKT-3 (anti-CD3 mAb) after 60 s (see arrow). The mean Ca
2+ flux is indicated by the blue
lines. B. Mean calcium mobilization upon TCR triggering for the indicated sterol conditions. C. Maximum fluorescence intensity of Fluo-4-labeled
Jurkat cells (15–40 cells per condition) stimulated anti-CD3-mAb adhered to microscopy coverslips. No differences between cell conditions were
found (P.0.05).
doi:10.1371/journal.pone.0002262.g004
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PLoS ONE | www.plosone.org 7 May 2008 | Volume 3 | Issue 5 | e2262role of this membrane condensation in the activation of T
lymphocytes. We found that enrichment of T cell membranes with
7-ketocholesterol (7KC) specifically inhibits membrane condensa-
tion at T cell activation sites. Following TCR activation 7KC–
enriched cells exhibit normal early TCR signaling responses such
as induction of calcium fluxes and phosphorylation of signaling
proteins when whole cell lysates were examined. However, TCR
triggering results in fewer TCR signaling complexes in the plasma
membrane, reduced accumulation of tyrosine phosphorylated
proteins on the cell surface and impaired re-structuring of actin
cytoskeleton at the activation sites in 7KC-enriched T cells. Such
differential localization of signaling activities correlates with an
inhibition of the late response, IL-2 secretion following prolonged
stimulation. Taken together, our data indicates that plasma
membrane condensation is required for the sustained T cell
activation process by possibly retaining signaling activities on the
cell surface and that lipid-driven interactions are an important
mediator of this condensation.
Figure 5. Signaling activities upon TCR triggering in whole cell lysates. A. Control and sterol-enriched Jurkat cells were activated with 5 mg
of UCHT1 (anti-CD3 mAb) for the indicated periods of time. Whole cell lysates were probed for ZAP70 phosphorylated at tyrosine 319. B.
Quantification of tyrosine 319 phosphorylation of ZAP70. The data show the mean and range of two independent experiments. C. Multiplex analysis
of T cell signaling. 2610
6 sterol-enriched Jurkat wt cells were activated with 5 mg/ml of anti-CD3 UCHT1 antibody for 0-15 min at 37uC. Non-site
specific tyrosine phosphorylation of CD3e, Lck, ZAP70, LAT and ERK1/2 (Tyr185/Tyr187) as well as serine phosphorylation of CREB (Ser133) in whole
cell lysates was assessed by multiplex microbead suspension assay. The data is one representative experiment; error bars represent standard
deviations. Legend shown in B applies to data in C.
doi:10.1371/journal.pone.0002262.g005
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PLoS ONE | www.plosone.org 8 May 2008 | Volume 3 | Issue 5 | e2262An increasing number of reports suggest a link between altered
lipid homeostasis, as in hypercholesterolemia, and changes in
immune cell activity [34] and immune responses. For example,
failed T cell activation correlates with ganglioside expression in
systemic lupus erythematosus [35,36]. Cellular cholesterol levels
are implicated in impaired T cell signaling [18] and in determining
the internalization rates of surface receptors in anergic B cells [37].
Elucidating the molecular link between ordered membrane
domains and immune cell activation could thus be important for
the understanding of the effects of dyslipidemia on immune
functions.
The functional importance of raft domains in T cell activation
has been previously addressed by mbCD-mediated cholesterol
extraction. Indeed, DRM-association of several membrane-
anchored T cell signaling proteins, for example LAT and Src
related tyrosine kinase Lck, is lost after cholesterol extraction [18].
However, mbCD treatment may also disturb other non-raft
related functions [13]. This is exemplified in the case of T cell
signaling by the inhibition of TCR triggering-induced Ca
2+ fluxes
by mbCD extraction, which is most likely due to the depletion of
Ca
2+ from intracellular stores [20] and thus independent of plasma
membrane rafts. However 7KC loading had no effect on the
induction of Ca
2+ fluxes following triggering of TCR. Thus the
machinery required for the induction of TCR-triggered Ca
2+
fluxes remains functional upon inhibition of membrane conden-
sation with 7KC. Furthermore, the general expression of T cell
signaling proteins and tyrosine phosphorylation rates as well as cell
viability are unaffected. This is strong evidence that the defective
T cell activation responses caused by 7KC incorporation are a
direct consequence of inhibition of membrane condensation at the
activation sites.
Enrichment with 7KC effectively prevented the formation of
ordered domains at T cell activation sites in a dose dependent
manner. 7KC differs from cholesterol by an additional ketone
group at the 7
th position of the sterol ring. The ketone group of
7KC protrudes perpendicular from the planar sterol ring and
limits the depth of 7KC insertion into the membrane and its
interaction with phospholipid acyl chains, orienting the two polar
moieties of the oxysterol near the membrane-water interface
[22,38]. Importantly, the alignment of the sterol ring of 7KC with
trans-configured saturated acyl chains of sphingo- and glyceroli-
pids is impaired, causing decreased formation of ordered
Figure 6. Formation of signaling complexes in sterol-enriched T cells. A. Sterol-treated Jurkat T cells (A control and 2:1 CH:7KC) were
conjugated with magnetic beads coated with anti-CD3 monoclonal antibodies. Cell-bead conjugates were activated for 0–15 min at 37uC and
subsequently homogenized by nitrogen cavitation at 4uC. Proteins from the recovered beads were separated by SDS page electrophoresis and
probed for signaling proteins CD3f, ZAP70, LAT and PLCc. Detection of proteins indicates recruitment to the activation site. The star denotes the
antibody heavy chain. B–D. Quantification of the recruitment of CD3f (B), ZAP70 (C) and LAT (D). One asterisk indicates a significant difference
compared to control cells (P,0.05); two asterisks indicate a significant difference compared to cholesterol-enriched cells (P,0.05).
doi:10.1371/journal.pone.0002262.g006
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PLoS ONE | www.plosone.org 10 May 2008 | Volume 3 | Issue 5 | e2262membrane domains [22]. The capability of an oxysterol to impair
cell membrane condensation suggests that the physical properties
of ordered domains in T cell membranes rely on the bilayer’s
sterol content and is thus lipid mediated.
Early TCR signals are transduced by TCR-LAT assemblies
(TLAs) which form in the plasma membrane by anchorage of
transmembrane linker protein LAT in the vicinity of triggered
TCR [5,30,32]. In an elegant study, Douglass and Vale
demonstrated that protein-protein interactions are the driving
force for TLAs [39] creating cooperative association of
cytoplasmic proteins with LAT clusters in the membrane
[40,41]. In response to TLAs, the membrane condenses at the
T cell activation site [17]. We propose that protein-mediated,
lateral clustering of LAT mediates plasma membrane condensa-
tion. LAT clustering and the anchoring of other raft-philic
proteins at the T cell activation sites may drive the recruitment of
pre-existing rafts or de novo formation of large raft domains. It is
noteworthy that LAT recruitment and phosphorylation at the cell
surface was more severely impaired by 7KC than signaling
proteins further upstream of LAT. The balance of protein- and
lipid-mediated interaction in the formation of TLAs remains to
be investigated. Our data further suggests TCR triggering
without membrane condensation results in insufficient signals
to polymerize actin around the activation site. This in turn
could affect the patterning of immunological synapses and thus
the internalization and recycling rates of TCR signaling clus-
ters. How membrane organization and actin restructuring are
linked on the molecular level is an important subject of future
research.
Materials and Methods
Cells and Reagents
Jurkat 8.2 cells, JCaM2 wtLAT cells, Jurkat cells and CH27 B
cells were maintained as described previously [17,42]. A1 (F)
RAG-1
2/2 CD4 T cells were isolated from spleen using
Dynabeads Mouse CD4 (L3T4) and DETACHaBEAD Mouse
CD4 (both Dynal Biotech) according to the manufacturers
recommendations. Purified CD4 T cells were expanded using
Mouse CD3/CD28 T cell expander (Dynal) in culture medium
supplemented with 10 U/ml IL-2 for 6–8 days. Expanded cells
were rested for 24h in IL-2 free medium before use. 7-
ketocholesterol (7KC, 5-cholesten-3b-ol-7-one) was purchased
from Steraloids (Newport, USA). Monoclonal antibodies KT3
(anti-mouse CD3) and OKT3 (anti-human CD3) were purified
from hybridoma supernatant and purchased from eBioscience,
respectively. Grb2 and ZAP-70 antibodies were purchased from
Transduction Laboratories. PLCc antibodies were from Cell
Signaling Tech and its phospho-specific analogue from BD
Biosciences. Phospho-specific ZAP70 and LAT antibodies were
purchased from Cell Signaling Tech and Biosource, respectively.
LAT rabbit antiserum was from Upstate Laboratories. Anti-b-
actin (goat) was purchased from Abcam and anti-CD3c (goat)
from Santa Cruz.
Sterol treatment
Aqueous stock solutions of 50 mg/mL methyl-ß-cyclodextrin
(mßCD) complexed to 1.5 mg/mL sterol were prepared as
described previously [43]. In brief, 5% mßCD in water was
heated to 80uC and 4610 mL aliquots of 15 mg/mL sterol in
ethanol added every 5–10 min. 1–10610
6 cells were incubated
with 15 mL (total) of mßCD-cholesterol, mßCD-7KC or a
combination of the two sterols in 1mL RPMI supplemented with
1 mg/mL BSA and 50 mM HEPES for 30 min at 37uC. Cells
were washed twice and conjugated, activated or lysed for sterol
and gene analysis. Cellular sterols were extracted with hexane/
methanol and analyzed on a reverse phase HPLC system as
previously described [21].
T cell activation
Jurkat, JCaM2 wt LAT or CD4 T cells were incubated with
anti-CD3 antibody (OKT3)-coated M450 Dynabeads (Dynal) for
isolation [30] or antibody-coated polystyrene beads [17] for
microscopy on ice (bead to cell ratio 1:2) and activated for the
indicated time at 37uC. Jurkat 8.2 cells (2 6 10
5) were activated
with B cell lymphoma cells CH27 (5610
5) in the presence or
absence of moth cytochrome c (MCC) peptide 86–103 [42]. For
microscopy CH27 were labeled with CMRA (CellTracker
Orange, Invitrogen) [17].
Figure 8. IL-2 secretion from stimulated sterol-enriched T cells.
Jurkat 8.2 cells (A) and primary mouse T lymphocytes (B) were sterol
treated with cholesterol and 7-ketocholesterol at the indicated ratios.
Jurkat 8.2 cells were stimulated with antigen-conjugated B cells (A) and
antigen exposed mouse T lymphocytes were activated with anti-CD3
mAb-coated beads (B). IL-2 secretion was determined by ELISA after 24h
incubation. One and two asterisks indicates a significant difference to
control cells of P,0.05 and P,0.001, respectively.
doi:10.1371/journal.pone.0002262.g008
Figure 7. TIRF microscopy images of TCR activation sites of sterol-enriched T cells. Sterol-treated Jurkat cells were activated for 10 min on
anti-CD3 mAb-coated glass coverslips, fixed and stained for phosphotyrosine (pY, A), phalloidin (B), ZAP70 phosphorylated at tyrosine 319 (D), LAT
phosphorylated at tyrosine 191 (E) or PLCc1 phosphorylation at tyrosine 783 (F). T cell activation sites were imaged by TIRF microscopy with a
penetration depth of ,100 nm. Panel C show the merged images with pY in green and F-actin in red. Bar 5 mm.
doi:10.1371/journal.pone.0002262.g007
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Verdi/Mira 900 multi-photon laser system and images were
recorded simultaneously with emission in the range of 400–460nm
and 470–530nm with a DM IRE2 Microscope (Leica, Australia)
[24]. Microscopy calibrations were performed as described
previously [23]. For other fluorescence and transmission images
a helium-neon laser was used to excite CMRA (Ex: 543nm, Em:
550–620nm) and record transmission images (Ex: 633nm, Em:
650–720nm), respectively. For all images a 1006 oil objective,
NA=1.4 was used and imaged at RT.
Image analysis
The Generalised Polarisation, GP, defined as
GP~
I 400{460 ðÞ {I 470{530 ðÞ
I 400{460 ðÞ zI 470{530 ðÞ
was calculated for each pixel using the two Laurdan intensity
images, using the software WIT [24]. GP images were pseudo-
colored in Adobe Photoshop. To determine GP values at
activation sites or synapses, the mean GP area of the region of
interest adjacent to the bead or APC was determined as previously
described [17]. GP distributions were obtained from the
histograms of the GP images, normalized (sum=100) and fitted
to two Gaussian distributions using the non-linear fitting algorithm
(Microsoft Excel).
TIRF microscopy
TIRF images were recorded with a Axiovert 200M microscope
(Zeiss) and a 1006 Plan-FLUAR objective (Zeiss), NA=1.4 as
previously described [44]. Images were acquired with a 16-bit
MicroMAX:512BFT CCD camera (Roper Scientific) driven by
Metamorph (Universal Imaging). Exposure time for all images was
100 ms. Fluorescein isothiocyanate (FITC) and tetramethylrhoda-
mine-isothiocyanate (TRITC) were excited with a multi-line
Innova 900 laser (Coherent Scientific) at 488 nm coupled to a
dual-port TIRF condenser (Till Photonics). Filter sets were from
Chroma Technology Corp.
Immunoisolation
Immunoisolations were performed as described previously [40].
Briefly, 5610
7 cells were incubated with antibody coated M500-
subcellular beads (Dynal) for the indicated time at 37uC. The
bead-cell conjugates were N2-cavitated using a nitrogen cavitation
bomb (Model 4639, Parr Instrument Company), beads were
retrieved with a magnet and subjected to immunoblotting analysis.
Proteins or 30 mg of cell lysates were separated by 10% SDS-
PAGE and transferred to Immobilon-P (Millipore) followed by
incubation with primary antibodies and the appropriate peroxi-
dase-conjugated secondary antibodies (Jackson Immunoresearch)
and ECL detection (Amersham Pharmacia Biotech).
Signaling
The signaling assay using Beadlyte 7-plex human TCR
signaling kit (Millipore) were carried out as described by the
manufacturer. Briefly, sterol-loaded and control Jurkat wt cells
were activated with anti-CD3 UCHT1 antibody (Millipore) at
37uC for the indicated time periods. Cells were lysed and cell
lysates incubated overnight with antibody-coated beads in 96-well,
filter-bottomed plates. Beads were washed and incubated with the
phospho-antibodies and detection reagents and analyzed with a
Bio-Plex 200 System (BioRad) instrument.
Calcium flux
5610
6 untreated or sterol-loaded Jurkat T cells were incubated
with 1 mM Indo-1 in 1ml RPMI (1% FCS) for 1h at 37uC in the
dark. Subsequently cells were washed twice and re-suspended in
1ml RPMI. Cells were kept on ice in the dark and analyzed on a
MoFlo (Cytomation) cell sorter at 37uC. The filter set-up for Indo-
1 was for calcium bound Indo-1 violet FL-5 405/20 nm filter and
unbound Indo-1 green FL-6 530/30 nm filter. Calcium flux was
measured as a ratio between calcium bound Indo-1 and unbound
or FL-5/FL-6. For localized stimuation, Fluo-4-labeled cells were
incubated with anti-CD3-coated glass coverslips and fluorescence
intensity recorded with an inverted microscope.
IL-2 secretion
2.5610
5 Jurkat 8.2 cells were incubated together with 5610
5
CH 27 B cells in 0.5 mL RPMI containing 10% FCS
and62.5 mg/mL antigen for 18–24 hours. Cells were removed
and the two aliquots of the supernatant (200 mL each) were used
for human interleukin-2 (IL-2) ELISA assay (eBioscience).
Background absorbance (determined from cells incubated without
antigen) was subtracted. IL-2 standards were used to determine
absolute IL-2 levels. For mouse IL-2 secretion, 96-well plates
(Corning) were coated with 10 mg/ml anti-CD3 mAb (KT3) at
4uC overnight. Subsequently wells were washed three times with
PBS and 2610
5 CD4 positive mouse T cells in 200 ml culture
medium were plated on each well. 50 ml aliquots of the culture
supernatant were used in a mouse IL-2 ELISA essay (eBioscience)
after 24h incubation at 37uC.
Cytotoxicity
10
6 T cells (sterol-loaded or control) were incubated in cell
culture medium for 24h at 37uC. The apoptosis and necrosis rate
in the incubated cultures was determined using the Annexin-V-
Fluos and propidium iodide staining kit (Roche Biosciences)
according to the manufacturer’s recommendations. Labeled
samples were analyzed on a FACScalibur (BD Bioscience)
fluorescence activated cell sorter. To determine caspase-3 activity,
2610
6 Jurkat wt cells (sterol-loaded and control) were lysed
(10 mM Tris-HCl pH 7.4, 130 mM NaCl, 1% Triton X-100) and
15 mg of each lysate was incubated with 20 mM of Ac-DEVD-
AMC (BD Biosciences) in protease assay buffer (40 mM HEPES
pH 7.5, 20% glycerol and 4 mM DTT) for 1h at 37uC.
Fluorescence emission upon Ac-DEVD-AMC cleavage was
determined in a plate spectrofluorometer (Ex: 380 nm; Em:
445 nm). Lysates from Jurkat wt cells treated with 2 mM
staurosporine (Sigma) for 4 h were used as a positive control. To
determine ROS generation, 10
6 Jurkat wt cells were pre-loaded
with 10 mM DHR (Invitrogen) for 30 min before sterol enrich-
ment. After 30 min incubation in culture media, the production of
ROS was measured by fluorescence intensity of DHR by flow
cytometry. To determine the mitochondrial membrane potential
10
6 Jurkat cells were labeled with 5 mg of JC-1 (Invitrogen) and the
red/green fluorescence shift analyzed by flow cytometry. The
cellular ATP content of Jurkat was measured using the ATP
bioluminescent assay kit from Sigma following the manufacturer
instructions.
CD3 surface expression
10
6 T cells were incubated with anti-CD3-FITC antibody
(eBioscience) for 1h at 4uC. The amount of surface fluorescence
in the stained cells was determined by flow cytometry was
analyzed using Weasel Flow Cytometry Software (WEHI,
Melbourne).
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Reverse transcription was performed with Superscript III
(Invitrogen) using 1 mg total RNA in each reaction. qRT-PCR
was performed on a RotorGene 3000 (Corbett Research) using
Quantace SensiMix SyBr Green reagent as the detection system.
b2 microglobulin was used as a housekeeping gene. Melting curve
analysis was performed for each PCR product at the end of each
run (confirming a single PCR product in each reaction).
Statistics
Multiple comparisons were compared with one-way, nonpara-
metric ANOVA with Tukey’s post-testing.
Supporting Information
Figure S1 FRET between tryptophan and Laurdan in activated
T cells. Jurkat cells were labeled with Laurdan concentrations of
0–75 mM and conjugated to anti-CD3 mAb-coated beads (bead to
cell ratio.1) for 10 min and fixed. A. 10
5 cell-bead conjugates
were resuspended in PBS in a quartz cuvette and tryptophan
fluorescence (Ex=28065 nm, Em=330610 nm), Laurdan
(Ex=40065 nm, Em=450610 nm) and FRET
(Ex=28065 nm, Em=450610 nm) determined. FRET values
were corrected for cross talk of Laurdan and tryptophan, which
was determined in egg PC liposomes and activated T cells without
Laurdan, respectively. Corrected FRET levels were normalized to
Laurdan intensity (FRET
L). The insert shows Laurdan intensity.
B. GP values at the activation site was determined for Jurkat cells
labeled with 2.5–75 mM Laurdan as described for Figure 2.
Activation sites contain 4–5% of total Laurdan fluorescence.
Means are indicated by horizontal lines and are: 0.43660.065
(2.5 mM), 0.44360.069 (5 mM), 0.44260.058 (10 mM),
0.47560.059 (25 mM), 0.48460.078 (50 mM) and 0.48560.059
(75 mM).
Found at: doi:10.1371/journal.pone.0002262.s001 (0.32 MB TIF)
Figure S2 Effects of sterol enrichment on mitochondria
potential (A), ATP levels (B), caspase-3 activity (C), ROS
generation (D), protein (E) and gene expression (F). A. Percentage
of cells with altered mitochondrial membrane potential (DY)a s
assessed by JC-1 staining and flow cytometry after sterol
treatment. Cells were sterols loaded for 30 minutes or treated
with 1mM H2O2 for 24 hours (positive control), and labeled with
JC-1 for 20 minutes. Data are from 3 independent experiments. B.
ATP content of Jurkat cells after sterol treatment. ATP levels of
control and sterol-loaded Jurkat cells were measured using a
luciferin/luciferase assay. Results are mean6SEM of four
experiments. C. Caspase-3 activity was assessed by the cleavage
of Ac-DEVD-AMC resulting in a fluorescent signaling. T cells
treated with 2mM staurosporine for 4 h were used as a positive
control (right y axis). 15 mg of lysate of sterol-enriched cells was
incubated with 20 mM of Ac-DEVD-AMC for 1 h at 37uC. No
difference in fluorescence intensity was found between control and
sterol-enriched cells. D. Jurkat cells pre-labeled with 10 mM DHR
(dihydrorhodamine 1,2,3) were either left untreated (control) or
enriched in sterols. Treatment with 500mM H2O2 for 30 min at
37uC was used as a positive control. DHR fluorescence indicates
the production of hydrogen peroxide (H2O2), hypochlorous acid
(HOCl) and peroxynitrite anion (ONOO
2). No significant
differences between control and sterol treatments were found. E.
Immunoblots of signaling proteins of whole cell lysates of wild-type
Jurkat and Jurkat 8.2 cells. F. Relative mRNA levels of sterol-
sensitive genes in Jurkat cells. Similar results were found in other
types of T cells. A–D. One asterisk indicates a significant
difference compared to control cells (P,0.05); two asterisks
indicate a significant difference compared to cholesterol-enriched
cells (P,0.05).
Found at: doi:10.1371/journal.pone.0002262.s002 (1.09 MB TIF)
Figure S3 Immunoisolation of cholesterol-treated Jurkat cells
and loading controls. A. Jurkat T cells (control or enriched in
cholesterol only) were conjugated with magnetic beads coated with
anti-CD3 monoclonal antibodies. Cell-bead conjugates were
activated for 3–15 min at 37uC and subsequently homogenized
by nitrogen cavitation at 4uC. Proteins from the recovered beads
were separated by SDS page electrophoresis and probed for
signaling proteins CD3f, ZAP70, LAT and PLCc. Detection of
proteins indicates recruitment to the activation site. Asterisk (*)
denotes the antibody heavy chain. B. Quantification of heavy
chain of the CD3 antibody conjugated to the beads in immuno-
isolated membrane fragments indicates similar protein recovery
from control, cholesterol- and 2:1 CH:7KC-enriched cells.
Found at: doi:10.1371/journal.pone.0002262.s003 (0.51 MB TIF)
Figure S4 Fluorescence intensity of TIRF images. A–B.
Maximum (hollow bars) and average fluorescence (filled bars)
intensity of anti-phosphotyrosine staining (A) and phalloidin
staining (B) were determined of 150–200 TIRF microscopy
images per sterol treatment and normalized to control cells.
Two asterisks indicate a significant difference to control cells of
P,0.001. C–E. Integrated intensity of 150–200 TIRF images
stained for ZAP70 phosphorylated at tryrosine 319 (C), LAT
phosphorylated at tyrosine 191 (D) or PLCc1 at tyrosine 783 (F).
A–E. One asterisks indicates a significant difference compared to
control cells (P,0.05); two asterisks indicate a significant
difference compared to cholesterol-enriched cells (P,0.05).
Found at: doi:10.1371/journal.pone.0002262.s004 (0.58 MB TIF)
Figure S5 Down-stream responses and responsiveness of sterol-
enriched T cells. A. Phosphorylation of ERK1/2, expressed
relative to total ERK1/2 in sterol-enriched T cells after 24 h
activation with 5 mg of OKT3 (anti-CD3 antibody). B. IL-2
luciferase activity in sterol-enriched T cells treated with 1 mM
ionomycin and 1 mM PMA for 24 h at 37uC. One asterisks
indicates a significant difference compared to control cells
(P,0.05); two asterisks indicate a significant difference compared
to cholesterol-enriched cells (P,0.05).
Found at: doi:10.1371/journal.pone.0002262.s005 (0.25 MB TIF)
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